Trial intelligence / Profile preview

Liraglutide in Brain Death for Organ Transplantation

NCT03672812Phase 3Completed

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Sep 2018
Primary completion
Dec 2019
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of liraglutide in brain death, sponsored by Hospital de Clínicas de Porto Alegre. Started Sep 2018; status: completed.

02

Drugs

03

Conditions

brain death

Beyond the preview

Go deeper on NCT03672812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03672812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call